We are live on ! Find out more
P

Pitcairn Portfolio holdings

AUM $1.27B
1-Year Est. Return 23.64%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+23.64%
3 Year Est. Return
+111.21%
5 Year Est. Return
+126.49%
10 Year Est. Return
+390.83%
AUM
$866M
AUM Growth
-$39.8M
Cap. Flow
-$74.6M
Cap. Flow %
-8.62%
Top 10 Hldgs %
45.27%
Holding
519
New
33
Increased
93
Reduced
336
Closed
48

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.96M
2
MRK icon
Merck
MRK
+$1.75M
3
META icon
Meta Platforms (Facebook)
META
+$1.53M
4
WBD icon
Warner Bros
WBD
+$1.38M
5
FLS icon
Flowserve
FLS
+$1.36M

Sector Composition

Rank Sector Weight
1 Consumer Staples 26.77%
2 Financials 9.04%
3 Healthcare 8.58%
4 Technology 7.65%
5 Industrials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABEV icon
101
Ambev
ABEV
$48.4B
$1.61M 0.19%
263,848
-11,837
-4% -$73.1K
AA icon
102
Alcoa
AA
$12.4B
$1.61M 0.19%
60,005
+23,308
+64% +$722K
RDS.A
103
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.6M 0.18%
28,014
FAST icon
104
Fastenal
FAST
$51.7B
$1.59M 0.18%
150,524
-168,064
-53% -$1.77M
BIDU icon
105
Baidu
BIDU
$36.6B
$1.54M 0.18%
7,763
+484
+7% +$99.1K
EA icon
106
Electronic Arts
EA
$52.4B
$1.54M 0.18%
23,104
-1,097
-5% -$67.5K
BHI
107
DELISTED
Baker Hughes
BHI
$1.51M 0.18%
24,547
-2,036
-8% -$133K
PFE icon
108
Pfizer
PFE
$142B
$1.51M 0.17%
47,403
-7,511
-14% -$245K
MMM icon
109
3M
MMM
$90.3B
$1.47M 0.17%
11,391
-153
-1% -$20.5K
MD icon
110
Pediatrix Medical
MD
$2.11B
$1.47M 0.17%
19,771
-1,508
-7% -$109K
NOC icon
111
Northrop Grumman
NOC
$75B
$1.44M 0.17%
9,065
-247
-3% -$39.5K
CMCSA icon
112
Comcast
CMCSA
$85B
$1.43M 0.16%
47,444
-818
-2% -$24K
UL icon
113
Unilever
UL
$133B
$1.42M 0.16%
29,436
-352
-1% -$17.4K
ICF icon
114
iShares Select U.S. REIT ETF
ICF
$2.08B
$1.42M 0.16%
31,702
-6,312
-17% -$302K
G icon
115
Genpact
G
$5.12B
$1.41M 0.16%
66,178
-6,103
-8% -$137K
BAC icon
116
Bank of America
BAC
$432B
$1.4M 0.16%
82,342
+11,292
+16% +$186K
SLM icon
117
SLM Corp
SLM
$4.73B
$1.36M 0.16%
138,289
+29,600
+27% +$299K
CNC icon
118
Centene
CNC
$33B
$1.35M 0.16%
+33,702
New +$1.21M
JNPR
119
DELISTED
Juniper Networks
JNPR
$1.35M 0.16%
52,037
-2,196
-4% -$57.7K
ABBV icon
120
AbbVie
ABBV
$453B
$1.34M 0.15%
19,902
+1,093
+6% +$71.4K
NSC icon
121
Norfolk Southern
NSC
$74.4B
$1.31M 0.15%
15,009
+9,735
+185% +$949K
WY icon
122
Weyerhaeuser
WY
$17B
$1.3M 0.15%
41,399
+3,372
+9% +$108K
REGN icon
123
Regeneron Pharmaceuticals
REGN
$70.1B
$1.27M 0.15%
2,483
-296
-11% -$144K
QGENF
124
DELISTED
QIAGEN NV
QGENF
$1.26M 0.15%
50,910
-2,146
-4% -$53.2K
DKS icon
125
Dick's Sporting Goods
DKS
$18.6B
$1.25M 0.14%
24,076
-4,167
-15% -$229K

Similar funds

Pitcairn's Q2 2015 Portfolio in Review

As of Q2 2015, Pitcairn held 519 positions worth $866M, down 4.4% from $905M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Pitcairn withdrew a net $74.6M in Q2 2015, closing 48 positions and reducing 336 holdings. Its most notable exit was CATAMARAN CORP COM STK (CDA), an estimated $1.8M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 27% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Pitcairn opened a new position in Centene worth $1.35M.

  • Pitcairn's largest Q2 2015 buy was Centene: 33,702 shares worth $1.35M.
  • Pitcairn added most to Eli Lilly in Q2 2015, an estimated $1.96M increase.
  • Pitcairn's biggest Q2 2015 reduction was iShares Russell 3000 ETF, cutting an estimated $6.74M.
  • Pitcairn fully exited CATAMARAN CORP COM STK (CDA) in Q2 2015, selling an estimated $1.8M.
  • Pitcairn's ten largest holdings make up 45% of its $866M portfolio in Q2 2015.
  • Pitcairn opened 33 new positions and closed 48 in Q2 2015.
  • Pitcairn's portfolio value fell 4.4% quarter-over-quarter to $866M.

Based on Pitcairn's 13F filing for Q2 2015, filed 6 Aug 2015.